Barclays’s Arvinas ARVN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $597K | Sell |
56,357
-112,050
| -67% | -$1.39M | ﹤0.01% | 3080 |
|
|
2025
Q4 | $2M | Sell |
168,407
-1,562
| -0.9% | -$17.1K | ﹤0.01% | 2934 |
|
|
2025
Q3 | $1.45M | Sell |
169,969
-50,864
| -23% | -$386K | ﹤0.01% | 3123 |
|
|
2025
Q2 | $1.63M | Buy |
220,833
+80,964
| +58% | +$596K | ﹤0.01% | 3011 |
|
|
2025
Q1 | $982K | Sell |
139,869
-35,150
| -20% | -$551K | ﹤0.01% | 3123 |
|
|
2024
Q4 | $3.36M | Buy |
175,019
+53,320
| +44% | +$1.3M | ﹤0.01% | 2494 |
|
|
2024
Q3 | $3M | Buy |
121,699
+80,984
| +199% | +$2.11M | ﹤0.01% | 2515 |
|
|
2024
Q2 | $1.08M | Sell |
40,715
-14,759
| -27% | -$470K | ﹤0.01% | 2554 |
|
|
2024
Q1 | $2.29M | Sell |
55,474
-28,147
| -34% | -$1.23M | ﹤0.01% | 2456 |
|
|
2023
Q4 | $3.44M | Buy |
83,621
+49,824
| +147% | +$1.16M | ﹤0.01% | 2436 |
|
|
2023
Q3 | $664K | Buy |
33,797
+7,228
| +27% | +$177K | ﹤0.01% | 2618 |
|
|
2023
Q2 | $659K | Sell |
26,569
-7,772
| -23% | -$200K | ﹤0.01% | 2577 |
|
|
2023
Q1 | $938K | Buy |
34,341
+11,158
| +48% | +$352K | ﹤0.01% | 2776 |
|
|
2022
Q4 | $793K | Sell |
23,183
-13,593
| -37% | -$572K | ﹤0.01% | 2988 |
|
|
2022
Q3 | $1.64M | Buy |
36,776
+15,985
| +77% | +$776K | ﹤0.01% | 1891 |
|
|
2022
Q2 | $875K | Sell |
20,791
-202,103
| -91% | -$10.1M | ﹤0.01% | 2464 |
|
|
2022
Q1 | $15M | Sell |
222,894
-87,927
| -28% | -$5.99M | 0.01% | 782 |
|
|
2021
Q4 | $25.5M | Buy |
310,821
+8,632
| +3% | +$702K | 0.01% | 854 |
|
|
2021
Q3 | $24.8M | Buy |
302,189
+58,711
| +24% | +$5.19M | 0.01% | 799 |
|
|
2021
Q2 | $18.7M | Sell |
243,478
-29,154
| -11% | -$2.02M | 0.01% | 922 |
|
|
2021
Q1 | $18M | Buy |
272,632
+22,787
| +9% | +$1.74M | 0.01% | 838 |
|
|
2020
Q4 | $21.2M | Buy |
249,845
+77,973
| +45% | +$2.69M | 0.01% | 817 |
|
|
2020
Q3 | $4.06M | Buy |
171,872
+44,718
| +35% | +$1.3M | ﹤0.01% | 1536 |
|
|
2020
Q2 | $4.26M | Buy |
127,154
+38,906
| +44% | +$1.65M | ﹤0.01% | 1500 |
|
|
2020
Q1 | $3.56M | Buy |
88,248
+20,060
| +29% | +$938K | ﹤0.01% | 1767 |
|
|
2019
Q4 | $2.8M | Sell |
68,188
-20,632
| -23% | -$604K | ﹤0.01% | 2644 |
|
|
2019
Q3 | $1.91M | Buy |
88,820
+75,733
| +579% | +$1.86M | ﹤0.01% | 2921 |
|
|
2019
Q2 | $288K | Buy |
13,087
+1,930
| +17% | +$40.6K | ﹤0.01% | 4791 |
|
|
2019
Q1 | $165K | Buy |
+11,157
| New | +$198K | ﹤0.01% | 4967 |
|
|
2018
Q4 | – | Sell |
-10,000
| Closed | -$169K | – | 6914 |
|
|
2018
Q3 | $169K | Buy |
+10,000
| New | +$165K | ﹤0.01% | 5145 |
|
Other funds holding ARVN
VPM
P
VCM
TCM
AC
Barclays's ARVN Position: Q1 2026 in Review
Barclays reduced its Arvinas (ARVN) stake by 67% in Q1 2026, selling an estimated $1.39M and leaving 56,357 shares worth $597K. The position accounts for ﹤0.01% of the portfolio, ranked #3080.
Barclays first reported a position in ARVN in Q3 2018 and has held it in 30 quarters since. The position peaked at $25.5M in Q4 2021. 206 funds tracked by Wall St. Rank hold ARVN as of Q1 2026.
- Barclays held 56,357 shares of Arvinas worth $597K as of Q1 2026.
- Barclays sold 112,050 Arvinas shares in Q1 2026, an estimated $1.39M.
- Arvinas made up ﹤0.01% of Barclays's portfolio in Q1 2026, its #3080 holding.
- Barclays first reported a position in Arvinas in Q3 2018 and has held it in 30 quarters since.
- Barclays's Arvinas position peaked at $25.5M in Q4 2021.
- 206 funds tracked by Wall St. Rank held Arvinas as of Q1 2026.
Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.